Navigation Links
American Cancer Society Expands Efforts to Reduce Burden of Cancer in Underserved Communities
Date:9/17/2013

ATLANTA, Sept. 17, 2013 /PRNewswire-USNewswire/ -- The American Cancer Society will provide more people in underserved communities with access to cancer screenings and community-based cancer education thanks to the generosity of Walgreens and its customers. The $6.4 million gift, raised through customers via electronic donations at checkout, will help fund the American Cancer Society's ongoing community-based initiatives aimed at reducing cancer disparities in communities with higher burdens of the disease.

The $6.4 million goes towards the Walgreens Way to Well Commitment® program that helps support the Society's Community Health Advocates implementing Nationwide Grants for Empowerment and Equity (CHANGE) program, which provides grant opportunities to increase breast, cervical and colorectal cancer screening rates in communities with a high burden of cancer. Since 2011, CHANGE has implemented 98 projects within underserved communities across the country; educating nearly 300,000 individuals about cancer risk and prevention, and providing nearly 118,000 cancer screenings.  

"The American Cancer Society is committed to finishing the fight against cancer in every community," said John R. Seffrin, Ph.D., chief executive officer of the American Cancer Society. "We are grateful to Walgreens for its support of our lifesaving work, especially in communities that carry a disproportionate burden of cancer."

"Walgreens' purpose is to help people get, stay and live well, and our Way to Well Commitment is dedicated to providing resources that aid with the prevention and detection of today's leading diseases," said John Gremer, director of community affairs at Walgreens.  "We'd like to thank our customers for their contributions that help us impact countless people across the country."

The Walgreens Way to Well Commitment® program, which focuses on improving everyday health through the prevention and early detection of today's leading diseases, has been a supporter of the Society's CHANGE grant program since 2011, but its overall corporate support of the American Cancer Society spans two decades and has helped raise a total of $23 million to date. In addition to funding the CHANGE program, Walgreens serves as a corporate enrollment site for Cancer Prevention Study 3 (CPS-3), the historic research study that's helping the American Cancer Society discover more ways to prevent cancer and save lives.  

According to the American Cancer Society, early detection of cancer, which usually results in less extensive treatment and better outcomes, can also be achieved through screening for some cancers – screening is known to reduce deaths from cancers of the breast, colon, rectum and cervix. However, racial and ethnic minorities and uninsured individuals are more likely to develop and die from cancer due to socioeconomic status and cultural barriers to high quality cancer prevention, early detection, and treatment services.

As part of a comprehensive cancer prevention and early detection effort, the American Cancer Society aims to eliminate cancer disparities by collaborating with community partners to increase awareness of ways to reduce the risk of cancer and the importance of regular screening.  

About the American Cancer Society
The American Cancer Society is a global grassroots force of more than three million volunteers saving lives and fighting for every birthday threatened by every cancer in every community. As the largest voluntary health organization, the Society's efforts have contributed to a 20 percent decline in cancer death rates in the U.S. since 1991, and a 50 percent drop in smoking rates. Thanks in part to our progress nearly 14 million Americans who have had cancer and countless more who have avoided it will celebrate more birthdays this year. As we mark our 100th birthday in 2013, we're determined to finish the fight against cancer. We're finding cures as the nation's  largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings, clean air, and more. For more information, to get help, or to join the fight, call us anytime, day or night, at 1-800-227-2345 or visit cancer.org.

About Walgreens
As the nation's largest drugstore chain with fiscal 2012 sales of $72 billion, Walgreens (www.walgreens.com) vision is to be the first choice in health and daily living for everyone in America, and beyond. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,105 drugstores in all 50 states, the District of Columbia and Puerto Rico. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health and wellness centers, medical practices, and in-store convenient care clinics, with more than 700 locations throughout the country.


'/>"/>
SOURCE American Cancer Society
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a digital ... digital marketing strategies of thousands of pharmacies through its ... Austin Inno,s "50 on Fire" Award in ... "We,re pleased to accept the award as one of ... Chief Executive Officer at RxWiki. "Our platform gives independent ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
(Date:12/8/2016)... , Dec. 8, 2016 Global Interventional ... on the global interventional radiology market analyzes the ... report comprises an elaborate executive summary, including a ... segments and sub-segments. The research is a ... formed the bulk of our research efforts along ...
Breaking Medicine Technology:
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
Breaking Medicine News(10 mins):